Table 4 Characteristics that predict use of molecular tests among lung cancer patients
Variable | OR | P Value | 95% CI |
|---|---|---|---|
Demographic characteristics | |||
Age (per year) | 0.99 | 0.00 | 0.99–0.99 |
Asian (vs. White) | 1.63 | 0.00 | 1.53–1.79 |
Black (vs. Whites) | 0.95 | 0.05 | 0.92–0.99 |
Hispanic (vs. Whites) | 0.87 | 0.03 | 0.78–0.99 |
Female (vs. Whites) | 1.18 | 0.00 | 1.16–1.21 |
Medicaid recipient (vs. all others) | 0.74 | 0.00 | 0.72–0.77 |
Distance to NCI Cancer Center (per mile) | 0.99 | 0.00 | 0.99–0.99 |
Number of lung cancers patient in HRR | 0.99 | 0.01 | 0.99–0.99 |
Clinical characteristics (vs. all others) | |||
Transcatheter biopsy | 2.54 | 0.00 | 2.49–2.60 |
TBNA | 1.53 | 0.00 | 1.48–1.59 |
Inpatient stay | 1.48 | 0.00 | 1.45–1.51 |
Thoracoscopy | 1.42 | 0.00 | 1.36–1.48 |
Mediastinoscopy | 1.35 | 0.00 | 1.30–1.41 |
EBUS | 1.32 | 0.00 | 1.27–1.38 |
Bronchoscopy | 1.24 | 0.00 | 1.21–1.27 |
Open surgery | 1.17 | 0.00 | 1.13–1.22 |
VATS | 1.14 | 0.00 | 1.09–1.20 |
Year identified | 1.09 | 0.00 | 1.09–1.12 |
HCC risk score | 0.77 | 0.00 | 0.76–0.78 |
Regional characteristics | |||
Distance to NCI Cancer Center | 0.99 | 0.00 | 0.99–0.99 |
Number of lung cancer patient in HRR | 0.99 | 0.01 | 0.99–0.99 |
20 HRRs with increased likelihood of testing | |||
Boston, MA | 4.94 | 0.00 | 1.67–14.62 |
Los Angeles, CA | 4.94 | 0.00 | 2.08–11.71 |
East Long Island, NY | 4.25 | 0.00 | 1.92–9.43 |
Manhattan, NY | 2.99 | 0.00 | 1.69–5.31 |
Fort Lauderdale, FL | 2.89 | 0.00 | 2.12–3.95 |
Philadelphia, PA | 2.67 | 0.00 | 1.50–4.76 |
Camden, NJ | 2.57 | 0.00 | 1.48–4.48 |
Orlando, FL | 2.25 | 0.01 | 1.21–4.20 |
Anchorage, AK | 2.21 | 0.00 | 1.29–3.77 |
Springdale, AR | 2.08 | 0.03 | 1.09–4.00 |
Houston, TX | 1.93 | 0.01 | 1.14–3.24 |
Atlanta, GA | 1.83 | 0.04 | 1.02–3.30 |
St. Louis, MO | 1.71 | 0.03 | 1.04–2.79 |
Pittsburgh, PA | 1.66 | 0.01 | 1.13–2.43 |
Nashville, TN | 1.59 | 0.00 | 1.31–1.93 |
Miami, FL | 1.49 | 0.00 | 1.23–1.80 |
Columbus, OH | 1.44 | 0.00 | 1.17–1.76 |
Seattle, WA | 1.39 | 0.01 | 1.09–1.76 |
Fort Myers, FL | 1.37 | 0.03 | 1.03–1.82 |
Kansas City, MO | 1.32 | 0.00 | 1.12–1.55 |
20 HRRs with lowest likelihood of testing | |||
Cape Girardeau, MO | 0.26 | 0.00 | 0.12–0.56 |
Binghamton, NY | 0.25 | 0.00 | 0.12–0.54 |
St. Cloud, MN | 0.25 | 0.00 | 0.10–0.61 |
La Crosse, WI | 0.24 | 0.00 | 0.10–0.57 |
Corpus Christi, TX | 0.24 | 0.00 | 0.11–0.51 |
San Angelo, TX | 0.24 | 0.00 | 0.09–0.59 |
Abilene, TX | 0.23 | 0.00 | 0.10–0.51 |
Covington, KY | 0.23 | 0.00 | 0.10–0.50 |
Longview, TX | 0.22 | 0.00 | 0.09–0.53 |
Slidell, LA | 0.21 | 0.00 | 0.09–0.53 |
Grand Forks, ND | 0.21 | 0.00 | 0.09–0.53 |
Tuscaloosa, AL | 0.21 | 0.00 | 0.09–0.48 |
Wichita Falls, TX | 0.20 | 0.00 | 0.08–0.47 |
Sayre, PA | 0.18 | 0.00 | 0.07–0.46 |
Texarkana, AR | 0.16 | 0.00 | 0.07–0.38 |
Idaho Falls, ID | 0.16 | 0.00 | 0.05–0.48 |
Alexandria, LA | 0.15 | 0.00 | 0.06–0.34 |
Rochester, MN | 0.15 | 0.00 | 0.06–0.35 |
Rome, GA | 0.12 | 0.00 | 0.05–0.28 |
Mason City, IA | 0.10 | 0.00 | 0.04–0.30 |